Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
173 hedge funds and large institutions have $726M invested in Meridian Bioscience Inc in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 67 increasing their positions, 51 reducing their positions, and 18 closing their positions.
31% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 51
2% less capital invested
Capital invested by funds: $744M → $726M (-$17.9M)
4% less funds holding
Funds holding: 180 → 173 (-7)
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
60% less call options, than puts
Call options by funds: $655K | Put options by funds: $1.62M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PP
Prudential plc
London, England,
United Kingdom
|
+$8.84M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.96M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.23M |
| 4 |
Renaissance Technologies
New York
|
+$3.01M |
| 5 |
AAM
ACK Asset Management
Greenwich,
Connecticut
|
+$2.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
-$10.1M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$8.99M |
| 3 |
Bank of New York Mellon
New York
|
-$5.41M |
| 4 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$2.33M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.48M |
VIVO Hedge Fund Activity: Q3 2016 in Review
173 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2016, worth a combined $726M — down 2.4% from $744M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of VIVO and 11 opened new positions — a net loss of 7 holders — while 51 trimmed existing stakes and 67 added.
The largest buyer was Prudential plc, adding an estimated $8.84M. The largest seller was Schroder Investment Management Group, cutting an estimated $10.1M.
- 173 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2016, down from 180 in Q2 2016.
- Funds reported $726M of Meridian Bioscience Inc stock for Q3 2016, down 2.4% quarter-over-quarter.
- 11 funds opened new Meridian Bioscience Inc positions in Q3 2016 and 18 closed out, a net change of -7 holders.
- The largest Meridian Bioscience Inc buyer in Q3 2016 was Prudential plc, an estimated $8.84M added.
- The largest Meridian Bioscience Inc seller in Q3 2016 was Schroder Investment Management Group, an estimated $10.1M sold.
Based on aggregated 13F filings for Q3 2016.